LEAVING OUR WEBSITE

You are now leaving our website.
Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.

EVER Pharma
EVER PharmaEVER Pharma
  • About Us
    • About Ever Pharma
    • Management
    • Business areas
    • Facts & Figures
    • Mission & Motivation
    • Company's history
    • Worldwide
  • Portfolio
    • Our Portfolio
    • Neurology
    • Specialty Injectables
  • Service & Partnerships
    • EVER Pharma Service & Partnerships
    • Contract Manufacturing
  • Career
  • Contact Us
    • Contact
    • Drug Safety
  • Search
     

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

Dedicated to health

PreviousNext

+++ EVER Pharma Launches Innovative, Patient Friendly Subcutaneous Pump for Parkinson´s Disease +++ EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe +++ EVER Valinject launches Dexmedetomidine in Europe +++ Another First for EVER Pharma: EVER Pharma is pleased to announce the first Fulvestrant in Europe approved for storage at room temperature +++

About us

Portfolio

Service & Partnerships

Career

News & Events

EVER PHARMA AND PARACELSUS MEDICAL PRIVATE UNIVERSITY DEEPEN THEIR COOPERATION

 

Although the Paracelsus Medical Private University (PMU) in Salzburg and...

  • Previous
  • 1
  • 2
  • 3
  • 4
  • ....
  • 9
  • Next
Products
  • Imprint
  • Data Privacy
  • Disclaimer
  • Sitemap

© 2021 EVER Neuro Pharma GmbH